Global Biosimilars/Follow-on-Biologics Market Growth 2020-2025
According to this study, over the next five years the Biosimilars/Follow-on-Biologics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilars/Follow-on-Biologics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars/Follow-on-Biologics market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Biosimilars/Follow-on-Biologics, covering the supply chain analysis, impact assessment to the Biosimilars/Follow-on-Biologics market size growth rate in several scenarios, and the measures to be undertaken by Biosimilars/Follow-on-Biologics companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Genentech (Roche Group)
Synthon Pharmaceuticals
LG Life Sciences
Celltrion
Teva Pharmaceutical Industries
Merck Group
Biocon
Biogen idec, Inc.
Hospira
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biosimilars/Follow-on-Biologics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Biosimilars/Follow-on-Biologics market by identifying its various subsegments.
Focuses on the key global Biosimilars/Follow-on-Biologics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biosimilars/Follow-on-Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biosimilars/Follow-on-Biologics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilars/Follow-on-Biologics Consumption 2015-2025
2.1.2 Biosimilars/Follow-on-Biologics Consumption CAGR by Region
2.2 Biosimilars/Follow-on-Biologics Segment by Type
2.2.1 Human Growth Hormone
2.2.2 Erythropoietin
2.2.3 Monoclonal Antibodies
2.2.4 Insulin
2.2.5 Interferon
2.2.6 Granulocyte-Colony Stimulating Factor
2.2.7 Peptide
2.2.8 Others
2.3 Biosimilars/Follow-on-Biologics Consumption by Type
2.3.1 Global Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
2.3.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Type (2015-2020)
2.4 Biosimilars/Follow-on-Biologics Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.4.3 Chronic and Autoimmune Diseases
2.4.4 Growth Hormone Deficiencies
2.4.5 Others
2.5 Biosimilars/Follow-on-Biologics Consumption by Application
2.5.1 Global Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
2.5.2 Global Biosimilars/Follow-on-Biologics Value and Market Share by Type (2015-2020)
2.5.3 Global Biosimilars/Follow-on-Biologics Sale Price by Type (2015-2020)
3 Global Biosimilars/Follow-on-Biologics by Company
3.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Company
3.1.1 Global Biosimilars/Follow-on-Biologics Sales by Company (2018-2020)
3.1.2 Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2018-2020)
3.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company
3.2.1 Global Biosimilars/Follow-on-Biologics Revenue by Company (2018-2020)
3.2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2018-2020)
3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Company
3.4 Global Biosimilars/Follow-on-Biologics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Biosimilars/Follow-on-Biologics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Biosimilars/Follow-on-Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Biosimilars/Follow-on-Biologics by Regions
4.1 Biosimilars/Follow-on-Biologics by Regions
4.2 Americas Biosimilars/Follow-on-Biologics Consumption Growth
4.3 APAC Biosimilars/Follow-on-Biologics Consumption Growth
4.4 Europe Biosimilars/Follow-on-Biologics Consumption Growth
4.5 Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Growth
5 Americas
5.1 Americas Biosimilars/Follow-on-Biologics Consumption by Countries
5.1.1 Americas Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
5.1.2 Americas Biosimilars/Follow-on-Biologics Value by Countries (2015-2020)
5.2 Americas Biosimilars/Follow-on-Biologics Consumption by Type
5.3 Americas Biosimilars/Follow-on-Biologics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Biosimilars/Follow-on-Biologics Consumption by Regions
6.1.1 APAC Biosimilars/Follow-on-Biologics Consumption by Regions (2015-2020)
6.1.2 APAC Biosimilars/Follow-on-Biologics Value by Regions (2015-2020)
6.2 APAC Biosimilars/Follow-on-Biologics Consumption by Type
6.3 APAC Biosimilars/Follow-on-Biologics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Biosimilars/Follow-on-Biologics by Countries
7.1.1 Europe Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
7.1.2 Europe Biosimilars/Follow-on-Biologics Value by Countries (2015-2020)
7.2 Europe Biosimilars/Follow-on-Biologics Consumption by Type
7.3 Europe Biosimilars/Follow-on-Biologics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Biosimilars/Follow-on-Biologics by Countries
8.1.1 Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Biosimilars/Follow-on-Biologics Value by Countries (2015-2020)
8.2 Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Type
8.3 Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilars/Follow-on-Biologics Distributors
10.3 Biosimilars/Follow-on-Biologics Customer
11 Global Biosimilars/Follow-on-Biologics Market Forecast
11.1 Global Biosimilars/Follow-on-Biologics Consumption Forecast (2021-2025)
11.2 Global Biosimilars/Follow-on-Biologics Forecast by Regions
11.2.1 Global Biosimilars/Follow-on-Biologics Forecast by Regions (2021-2025)
11.2.2 Global Biosimilars/Follow-on-Biologics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biosimilars/Follow-on-Biologics Forecast by Type
11.8 Global Biosimilars/Follow-on-Biologics Forecast by Application
12 Key Players Analysis
12.1 Novartis
12.1.1 Company Information
12.1.2 Biosimilars/Follow-on-Biologics Product Offered
12.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novartis Latest Developments
12.2 Genentech (Roche Group)
12.2.1 Company Information
12.2.2 Biosimilars/Follow-on-Biologics Product Offered
12.2.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Genentech (Roche Group) Latest Developments
12.3 Synthon Pharmaceuticals
12.3.1 Company Information
12.3.2 Biosimilars/Follow-on-Biologics Product Offered
12.3.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Synthon Pharmaceuticals Latest Developments
12.4 LG Life Sciences
12.4.1 Company Information
12.4.2 Biosimilars/Follow-on-Biologics Product Offered
12.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 LG Life Sciences Latest Developments
12.5 Celltrion
12.5.1 Company Information
12.5.2 Biosimilars/Follow-on-Biologics Product Offered
12.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Celltrion Latest Developments
12.6 Teva Pharmaceutical Industries
12.6.1 Company Information
12.6.2 Biosimilars/Follow-on-Biologics Product Offered
12.6.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Teva Pharmaceutical Industries Latest Developments
12.7 Merck Group
12.7.1 Company Information
12.7.2 Biosimilars/Follow-on-Biologics Product Offered
12.7.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Merck Group Latest Developments
12.8 Biocon
12.8.1 Company Information
12.8.2 Biosimilars/Follow-on-Biologics Product Offered
12.8.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Biocon Latest Developments
12.9 Biogen idec, Inc.
12.9.1 Company Information
12.9.2 Biosimilars/Follow-on-Biologics Product Offered
12.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Biogen idec, Inc. Latest Developments
12.10 Hospira
12.10.1 Company Information
12.10.2 Biosimilars/Follow-on-Biologics Product Offered
12.10.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hospira Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Biosimilars/Follow-on-Biologics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Human Growth Hormone
Table 5. Major Players of Erythropoietin
Table 6. Major Players of Monoclonal Antibodies
Table 7. Major Players of Insulin
Table 8. Major Players of Interferon
Table 9. Major Players of Granulocyte-Colony Stimulating Factor
Table 10. Major Players of Peptide
Table 11. Major Players of Others
Table 12. Global Consumption Sales by Type (2015-2020)
Table 13. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
Table 14. Global Biosimilars/Follow-on-Biologics Revenue by Type (2015-2020) ($ million)
Table 15. Global Biosimilars/Follow-on-Biologics Value Market Share by Type (2015-2020) ($ Millions)
Table 16. Global Biosimilars/Follow-on-Biologics Sale Price by Type (2015-2020)
Table 17. Global Consumption Sales by Application (2015-2020)
Table 18. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020)
Table 19. Global Biosimilars/Follow-on-Biologics Value by Application (2015-2020)
Table 20. Global Biosimilars/Follow-on-Biologics Value Market Share by Application (2015-2020)
Table 21. Global Biosimilars/Follow-on-Biologics Sale Price by Application (2015-2020)
Table 22. Global Biosimilars/Follow-on-Biologics Sales by Company (2017-2019) (K Pcs)
Table 23. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2017-2019)
Table 24. Global Biosimilars/Follow-on-Biologics Revenue by Company (2017-2019) ($ Millions)
Table 25. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2017-2019)
Table 26. Global Biosimilars/Follow-on-Biologics Sale Price by Company (2017-2019)
Table 27. Global Biosimilars/Follow-on-Biologics Manufacturing Base Distribution and Sales Area by Manufacturers
Table 28. Players Biosimilars/Follow-on-Biologics Products Offered
Table 29. Biosimilars/Follow-on-Biologics Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 30. Global Biosimilars/Follow-on-Biologics Consumption by Regions 2015-2020 (K Pcs)
Table 31. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Regions 2015-2020
Table 32. Global Biosimilars/Follow-on-Biologics Value by Regions 2015-2020 ($ Millions)
Table 33. Global Biosimilars/Follow-on-Biologics Value Market Share by Regions 2015-2020
Table 34. Americas Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020) (K Pcs)
Table 35. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Countries (2015-2020)
Table 36. Americas Biosimilars/Follow-on-Biologics Value by Countries (2015-2020) ($ Millions)
Table 37. Americas Biosimilars/Follow-on-Biologics Value Market Share by Countries (2015-2020)
Table 38. Americas Biosimilars/Follow-on-Biologics Consumption by Type (2015-2020) (K Pcs)
Table 39. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
Table 40. Americas Biosimilars/Follow-on-Biologics Consumption by Application (2015-2020) (K Pcs)
Table 41. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020)
Table 42. APAC Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020) (K Pcs)
Table 43. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Countries (2015-2020)
Table 44. APAC Biosimilars/Follow-on-Biologics Value by Regions (2015-2020) ($ Millions)
Table 45. APAC Biosimilars/Follow-on-Biologics Value Market Share by Regions (2015-2020)
Table 46. APAC Biosimilars/Follow-on-Biologics Consumption by Type (2015-2020) (K Pcs)
Table 47. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
Table 48. APAC Biosimilars/Follow-on-Biologics Consumption by Application (2015-2020) (K Pcs)
Table 49. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020)
Table 50. Europe Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020) (K Pcs)
Table 51. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Countries (2015-2020)
Table 52. Europe Biosimilars/Follow-on-Biologics Value by Countries (2015-2020) ($ Millions)
Table 53. Europe Biosimilars/Follow-on-Biologics Value Market Share by Countries (2015-2020)
Table 54. Europe Biosimilars/Follow-on-Biologics Consumption by Type (2015-2020) (K Pcs)
Table 55. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
Table 56. Europe Biosimilars/Follow-on-Biologics Consumption by Application (2015-2020) (K Pcs)
Table 57. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020)
Table 58. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020) (K Pcs)
Table 59. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Biosimilars/Follow-on-Biologics Value by Countries (2015-2020) ($ Millions)
Table 61. Middle East & Africa Biosimilars/Follow-on-Biologics Value Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Type (2015-2020) (K Pcs)
Table 63. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
Table 64. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Application (2015-2020) (K Pcs)
Table 65. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020)
Table 66. Biosimilars/Follow-on-Biologics Distributors List
Table 67. Biosimilars/Follow-on-Biologics Customer List
Table 68. Global Biosimilars/Follow-on-Biologics Consumption Forecast by Countries (2021-2025) (K Pcs)
Table 69. Global Biosimilars/Follow-on-Biologics Consumption Market Forecast by Regions
Table 70. Global Biosimilars/Follow-on-Biologics Value Forecast by Countries (2021-2025) ($ Millions)
Table 71. Global Biosimilars/Follow-on-Biologics Value Market Share Forecast by Regions
Table 72. Global Biosimilars/Follow-on-Biologics Consumption Forecast by Type (2021-2025) (K Pcs)
Table 73. Global Biosimilars/Follow-on-Biologics Consumption Market Share Forecast by Type (2021-2025)
Table 74. Global Biosimilars/Follow-on-Biologics Value Forecast by Type (2021-2025) ($ Millions)
Table 75. Global Biosimilars/Follow-on-Biologics Value Market Share Forecast by Type (2021-2025)
Table 76. Global Biosimilars/Follow-on-Biologics Consumption Forecast by Application (2021-2025) (K Pcs)
Table 77. Global Biosimilars/Follow-on-Biologics Consumption Market Share Forecast by Application (2021-2025)
Table 78. Global Biosimilars/Follow-on-Biologics Value Forecast by Application (2021-2025) ($ Millions)
Table 79. Global Biosimilars/Follow-on-Biologics Value Market Share Forecast by Application (2021-2025)
Table 80. Novartis Product Offered
Table 81. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Novartis Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 85. Genentech (Roche Group) Product Offered
Table 86. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 87. Genentech (Roche Group) Main Business
Table 88. Genentech (Roche Group) Latest Developments
Table 89. Genentech (Roche Group) Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 90. Synthon Pharmaceuticals Product Offered
Table 91. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 92. Synthon Pharmaceuticals Main Business
Table 93. Synthon Pharmaceuticals Latest Developments
Table 94. Synthon Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 95. LG Life Sciences Product Offered
Table 96. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 97. LG Life Sciences Main Business
Table 98. LG Life Sciences Latest Developments
Table 99. LG Life Sciences Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 100. Celltrion Product Offered
Table 101. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 102. Celltrion Main Business
Table 103. Celltrion Latest Developments
Table 104. Celltrion Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 105. Teva Pharmaceutical Industries Product Offered
Table 106. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 107. Teva Pharmaceutical Industries Main Business
Table 108. Teva Pharmaceutical Industries Latest Developments
Table 109. Teva Pharmaceutical Industries Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 110. Merck Group Product Offered
Table 111. Merck Group Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 112. Merck Group Main Business
Table 113. Merck Group Latest Developments
Table 114. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 115. Biocon Product Offered
Table 116. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 117. Biocon Main Business
Table 118. Biocon Latest Developments
Table 119. Biocon Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 120. Biogen idec, Inc. Product Offered
Table 121. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 122. Biogen idec, Inc. Main Business
Table 123. Biogen idec, Inc. Latest Developments
Table 124. Biogen idec, Inc. Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 125. Hospira Product Offered
Table 126. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E)
Table 127. Hospira Main Business
Table 128. Hospira Latest Developments
Table 129. Hospira Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Biosimilars/Follow-on-Biologics
Figure 2. Biosimilars/Follow-on-Biologics Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Biosimilars/Follow-on-Biologics Consumption Growth Rate 2015-2025 (K Pcs)
Figure 5. Global Biosimilars/Follow-on-Biologics Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Human Growth Hormone
Figure 7. Product Picture of Erythropoietin
Figure 8. Product Picture of Monoclonal Antibodies
Figure 9. Product Picture of Insulin
Figure 10. Product Picture of Interferon
Figure 11. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 12. Product Picture of Peptide
Figure 13. Product Picture of Others
Figure 14. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
Figure 15. Global Biosimilars/Follow-on-Biologics Value Market Share by Type (2015-2020)
Figure 16. Biosimilars/Follow-on-Biologics Consumed in Blood Disorders
Figure 17. Global Biosimilars/Follow-on-Biologics Market: Blood Disorders (2015-2020) (K Pcs)
Figure 18. Global Biosimilars/Follow-on-Biologics Market: Blood Disorders (2015-2020) ($ Millions)
Figure 19. Biosimilars/Follow-on-Biologics Consumed in Oncology Diseases
Figure 20. Global Biosimilars/Follow-on-Biologics Market: Oncology Diseases (2015-2020) (K Pcs)
Figure 21. Global Biosimilars/Follow-on-Biologics Market: Oncology Diseases (2015-2020) ($ Millions)
Figure 22. Biosimilars/Follow-on-Biologics Consumed in Chronic and Autoimmune Diseases
Figure 23. Global Biosimilars/Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2015-2020) (K Pcs)
Figure 24. Global Biosimilars/Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2015-2020) ($ Millions)
Figure 25. Biosimilars/Follow-on-Biologics Consumed in Growth Hormone Deficiencies
Figure 26. Global Biosimilars/Follow-on-Biologics Market: Growth Hormone Deficiencies (2015-2020) (K Pcs)
Figure 27. Global Biosimilars/Follow-on-Biologics Market: Growth Hormone Deficiencies (2015-2020) ($ Millions)
Figure 28. Biosimilars/Follow-on-Biologics Consumed in Others
Figure 29. Global Biosimilars/Follow-on-Biologics Market: Others (2015-2020) (K Pcs)
Figure 30. Global Biosimilars/Follow-on-Biologics Market: Others (2015-2020) ($ Millions)
Figure 31. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020)
Figure 32. Global Biosimilars/Follow-on-Biologics Value Market Share by Application (2015-2020)
Figure 33. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company in 2017
Figure 34. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company in 2019
Figure 35. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company in 2017
Figure 36. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company in 2019
Figure 37. Global Biosimilars/Follow-on-Biologics Sale Price by Company in 2019
Figure 38. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Regions 2015-2020
Figure 39. Global Biosimilars/Follow-on-Biologics Value Market Share by Regions 2015-2020
Figure 40. Americas Biosimilars/Follow-on-Biologics Consumption 2015-2020 (K Pcs)
Figure 41. Americas Biosimilars/Follow-on-Biologics Value 2015-2020 ($ Millions)
Figure 42. APAC Biosimilars/Follow-on-Biologics Consumption 2015-2020 (K Pcs)
Figure 43. APAC Biosimilars/Follow-on-Biologics Value 2015-2020 ($ Millions)
Figure 44. Europe Biosimilars/Follow-on-Biologics Consumption 2015-2020 (K Pcs)
Figure 45. Europe Biosimilars/Follow-on-Biologics Value 2015-2020 ($ Millions)
Figure 46. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption 2015-2020 (K Pcs)
Figure 47. Middle East & Africa Biosimilars/Follow-on-Biologics Value 2015-2020 ($ Millions)
Figure 48. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2019
Figure 49. Americas Biosimilars/Follow-on-Biologics Value Market Share by Countries in 2019
Figure 50. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Type in 2019
Figure 51. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Application in 2019
Figure 52. United States Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 53. United States Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 54. Canada Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 55. Canada Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 56. Mexico Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 57. Mexico Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 58. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2019
Figure 59. APAC Biosimilars/Follow-on-Biologics Value Market Share by Regions in 2019
Figure 60. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Type in 2019
Figure 61. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Application in 2019
Figure 62. China Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 63. China Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 64. Japan Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 65. Japan Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 66. Korea Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 67. Korea Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 68. Southeast Asia Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 69. Southeast Asia Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 70. India Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 71. India Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 72. Australia Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 73. Australia Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 74. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2019
Figure 75. Europe Biosimilars/Follow-on-Biologics Value Market Share by Countries in 2019
Figure 76. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Type in 2019
Figure 77. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Application in 2019
Figure 78. Germany Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 79. Germany Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 80. France Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 81. France Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 82. UK Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 83. UK Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 84. Italy Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 85. Italy Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 86. Russia Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 87. Russia Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 88. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2019
Figure 89. Middle East & Africa Biosimilars/Follow-on-Biologics Value Market Share by Countries in 2019
Figure 90. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Type in 2019
Figure 91. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Application in 2019
Figure 92. Egypt Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 93. Egypt Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 94. South Africa Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 95. South Africa Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 96. Israel Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 97. Israel Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 98. Turkey Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 99. Turkey Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 100. GCC Countries Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs)
Figure 101. GCC Countries Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions)
Figure 102. Global Biosimilars/Follow-on-Biologics Consumption Growth Rate Forecast (2021-2025) (K Pcs)
Figure 103. Global Biosimilars/Follow-on-Biologics Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 104. Americas Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 105. Americas Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 106. APAC Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 107. APAC Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 108. Europe Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 109. Europe Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 110. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 111. Middle East & Africa Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 112. United States Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 113. United States Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 114. Canada Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 115. Canada Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 116. Mexico Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 117. Mexico Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 118. Brazil Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 119. Brazil Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 120. China Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 121. China Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 122. Japan Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 123. Japan Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 124. Korea Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 125. Korea Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 126. Southeast Asia Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 127. Southeast Asia Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 128. India Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 129. India Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 130. Australia Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 131. Australia Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 132. Germany Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 133. Germany Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 134. France Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 135. France Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 136. UK Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 137. UK Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 138. Italy Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 139. Italy Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 140. Russia Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 141. Russia Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 142. Spain Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 143. Spain Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 144. Egypt Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 145. Egypt Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 146. South Africa Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 147. South Africa Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 148. Israel Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 149. Israel Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 150. Turkey Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 151. Turkey Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 152. GCC Countries Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs)
Figure 153. GCC Countries Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions)
Figure 154. Novartis Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 155. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 156. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 157. LG Life Sciences Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 158. Celltrion Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 159. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 160. Merck Group Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 161. Biocon Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 162. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Figure 163. Hospira Biosimilars/Follow-on-Biologics Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets